Combining GLP-1 medications with 8 healthy lifestyle habits reduced the risk of major adverse cardiovascular events, or MACE, ...

SHANGHAI, Feb 24 () - Pfizer has entered an agreement to license Sciwind Biosciences' type 2 diabetes treatment ‌ecnoglutide, ...

Type 2 diabetes occurs when the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood sugar levels. Medications aim to lower blood glucose, reduce A1C, and ...

A new study reveals that the world’s most widely used diabetes drug works through a previously unknown brain pathway ...

A large study of US veterans suggests that diabetes and weight-loss medicines may curb cravings and lower severe addiction outcomes, though clinical trials are still needed.

In particular, it’s been pretty common for a long time that people with type 1 diabetes take drugs that are only approved and labeled for type 2 diabetes. This is especially true for Metformin, the ...

By Hugo Francisco de Souza A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for ...

A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors-such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)-or ...

Add Yahoo as a preferred source to see more of our stories on Google. hand holding a pill, with another pill pouring from an orange prescription jar Not only can the drug metformin help to effectively ...

A large cohort study found three popular GLP-1-based diabetes drugs -- semaglutide, dulaglutide, and tirzepatide -- carry similar risks for serious adverse GI events, with a rate of about 12 per 1,000 ...

First new drug in 30 years to slow kidney disease in type 1 diabetes ...